Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DBV eyes European expansion with Bioprojet deal

This article was originally published in Clinica

Executive Summary

Epicutaneous diagnostics specialist DBV Technologies has signed a distribution deal for its Diallertest cow’s milk allergy test with Bioprojet pharma, a drug company specialising in paediatrics. The deal will see Bioprojet promote and distribute the test in France and perhaps beyond: Bioprojet CEO Jeanne-Marie Lecomte said that the firm was “looking forward to working with DBV to make Diallertest Milk more widely available throughout Europe”. Financial terms of the agreement were not revealed. Paris, France-based DBV said that it is currently working on further developing the Diallertest line to include diagnosis tools for wheat, soya and dustmite allergies in children.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044494

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel